Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
United Therapeutics Corporation (UTHR) had Gross Margin of 87.38% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$799.50M |
|
$338.70M |
|
$100.90M |
|
$698.60M |
|
$411.00M |
|
$388.50M |
|
$49.50M |
|
$438.00M |
|
$438.00M |
|
$338.70M |
|
$338.70M |
|
$338.70M |
|
$338.70M |
|
$388.50M |
|
$410.40M |
|
43.80M |
|
47.30M |
|
$7.73 |
|
$7.16 |
|
| Balance Sheet Financials | |
$3.49B |
|
$1.56B |
|
$3.86B |
|
$7.35B |
|
$546.30M |
|
-- |
|
$214.60M |
|
$760.90M |
|
$6.59B |
|
$6.47B |
|
$6.59B |
|
42.90M |
|
| Cash Flow Statement Financials | |
$1.22B |
|
$-323.70M |
|
$-1.25B |
|
$1.70B |
|
$1.34B |
|
$-357.10M |
|
$108.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
87.38% |
48.59% |
|
48.59% |
|
-- |
|
54.78% |
|
42.36% |
|
$867.40M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.57 |
|
2.69 |
|
33.51 |
|
5.14% |
|
5.23% |
|
4.61% |
|
5.14% |
|
$153.61 |
|
$18.34 |
|
$25.69 |
|